Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP)
- PMID: 35320118
- PMCID: PMC9004561
- DOI: 10.18632/aging.203972
Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP)
Abstract
The aim of the current study was to characterize ovarian reserve parameters and IVF outcomes in women with a history of poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP). Reproductive age women (N=510; age range 30-45yo) diagnosed with POR based on Poseidon criteria were included in the study. PRP treatment resulted in higher AFC, higher serum AMH, lower serum FSH, and a higher number of mature oocytes and cleavage and blastocyst stage embryos. After PRP injection, 22 women (4.3%) conceived spontaneously, 14 (2.7%) were lost to follow up, and 474 (92.9%) attempted IVF. Among women who attempted IVF, 312 (65.8%) generated embryos and underwent embryo transfer, 83 (17.5%) achieved a pregnancy, and 54 (11.4%) achieved sustained implantation/live birth (SI/LB). In total, of the 510 women with POR and mean age of 40.3, PRP resulted in improvement of ovarian reserve parameters, a pregnancy rate of 20.5% and SI/LB rate of 12.9%. Our findings suggest that PRP treatment may be considered in women with POR. For wider clinical application, its clinical efficacy will need to be demonstrated in prospective randomized clinical trials.
Keywords: in vitro fertilization; platelet rich plasma; poor ovarian response.
Conflict of interest statement
Figures
Similar articles
-
Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency.Aging (Albany NY). 2020 Jun 5;12(11):10211-10222. doi: 10.18632/aging.103403. Epub 2020 Jun 5. Aging (Albany NY). 2020. PMID: 32507764 Free PMC article.
-
Comparative efficacy of single vs. double autologous platelet-rich plasma ovarian injections for improving ovarian response in poor ovarian responders.Sci Rep. 2025 May 26;15(1):18292. doi: 10.1038/s41598-025-02689-2. Sci Rep. 2025. PMID: 40419615 Free PMC article.
-
Intra-ovarian platelet-rich plasma administration plus successive accumulated embryo transfer could be a promising strategy for poor ovarian response management: a before-after study.J Ovarian Res. 2025 Mar 28;18(1):64. doi: 10.1186/s13048-025-01646-x. J Ovarian Res. 2025. PMID: 40156028 Free PMC article.
-
The efficacy of platelet rich plasma on women with poor ovarian response: a systematic review and meta-analysis.Platelets. 2024 Dec;35(1):2292612. doi: 10.1080/09537104.2023.2292612. Epub 2024 Jan 12. Platelets. 2024. PMID: 38214306
-
The effect of ovarian injection of autologous platelet rich plasma in patients with poor ovarian responder: a systematic review and meta-analysis.Front Endocrinol (Lausanne). 2023 Dec 12;14:1292168. doi: 10.3389/fendo.2023.1292168. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38155954 Free PMC article.
Cited by
-
Successful Pregnancy Following Platelet-Rich Plasma Intraovarian Injection and In Vitro Maturation of Oocytes in a 47-Year-Old Woman: A Case Report.Cureus. 2024 Jul 24;16(7):e65281. doi: 10.7759/cureus.65281. eCollection 2024 Jul. Cureus. 2024. PMID: 39184795 Free PMC article.
-
Current Status and Future Prospects of Stem Cell Therapy for Infertile Patients with Premature Ovarian Insufficiency.Biomolecules. 2024 Feb 19;14(2):242. doi: 10.3390/biom14020242. Biomolecules. 2024. PMID: 38397479 Free PMC article. Review.
-
mTOR Inhibition via Low-Dose, Pulsed Rapamycin with Intraovarian Condensed Platelet Cytokines: An Individualized Protocol to Recover Diminished Reserve?J Pers Med. 2023 Jul 17;13(7):1147. doi: 10.3390/jpm13071147. J Pers Med. 2023. PMID: 37511761 Free PMC article.
-
Evaluation of intraovarian injection of platelet-rich plasma for enhanced ovarian function and reproductive success in women with POI and POR: a systematic review and meta-analysis.Eur J Med Res. 2025 Jul 10;30(1):610. doi: 10.1186/s40001-025-02854-3. Eur J Med Res. 2025. PMID: 40640939 Free PMC article.
-
Summary of the ISFP congress, Brussels, 10-12 November, 2022.J Assist Reprod Genet. 2023 Mar;40(3):433-442. doi: 10.1007/s10815-023-02720-3. Epub 2023 Feb 11. J Assist Reprod Genet. 2023. PMID: 36765026 Free PMC article. Review.
References
-
- Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org, and Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020; 114:1151–7. 10.1016/j.fertnstert.2020.09.134 - DOI - PubMed
-
- Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L, and ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011; 26:1616–24. 10.1093/humrep/der092 - DOI - PubMed
-
- Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, Esteves SC, Fischer R, Galliano D, Polyzos NP, Sunkara SK, Ubaldi FM, Humaidan P, and Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number). A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016; 105:1452–3. 10.1016/j.fertnstert.2016.02.005 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials